Table of Contents Table of Contents
Previous Page  451 / 1082 Next Page
Information
Show Menu
Previous Page 451 / 1082 Next Page
Page Background

S436

ESTRO 36 2017

_______________________________________________________________________________________________

A radiation oncologist found 96% of cervical cancer beam

apertures were clinically acceptable, with all failures

caused by a slight error in the position of the superior

border. The primary and secondary aperture calculations

agreed with average DICE and mean absolute distance of

0.93 and 5.5mm, respectively. An example is shown

below. Automated beam weighting reduced hotspots by

1.5% on average.

Conclusion

Normal tissue segmentation for head/neck cancer patients

and determination of the jaw/MLC for cervical cancer

patients are very successful. Both have been introduced

into use in our clinic. Next steps include full evaluation of

the resulting dose distributions, and assessing the use of

these techniques for a prototype linac with flattening-

filter-free beam and novel MLC design.

PO-0821 Automatic re-planning of VMAT plans in

prostate and HN patients using constrained optimization

L. Künzel

1

, O. Dohm

2

, M. Alber

3

, D. Thorwarth

1

1

University Hospital Tübingen Eberhard Karls University

Tübingen, Section for Biomedical Physics, Tübingen,

Germany

2

University Hospital Tübingen Eberhard Karls University

Tübingen, Radiation Oncology Division of Medical

Physics, Tübingen, Germany

3

University Hospital Heidelberg, Radiation Oncology,

Heidelberg, Germany

Purpose or Objective

To develop and evaluate a new concept for automatic re-

planning of VMAT plans as failure concept for solitary

treatment machines, e.g. MR-Linac. In contrast to

previously published automatic planning approaches

which replicate the planned dose distribution, we propose

an automatic re-planning concept which uses constrained

optimization to generate Pareto-optimal VMAT plans for

different treatment machines. The scheme interprets a

treatment plan as a point on the corresponding Pareto

front, and creates the re-planned one by projecting this

point onto the substitute´s Pareto front. Thereby,

comparable biological effect and hence clinical outcome

can be guaranteed.

Material and Methods

In this automatic re-planning study, n=16 prostate cancer

and n=19 head and neck cancer (HNC) cases were

included. All patients had previously planned clinical

VMAT plans created with in-house TPS Hyperion. Hyperion

uses constrained optimization where a Lagrange multiplier

λi is associated to each cost-function constraint Ci, rating

the effect of each organ-at-risk (OAR) constraint on the

target objective.

Automatic re-planning starts from the initially reached

optimal constraints Ci for PTVs and OARs and adapted

machine parameters. A full optimization was executed

automatically, in order to generate a comparable Pareto-

optimal plan. For prostate cases, Elekta BeamModulator

plans were re-planned for Elekta Agility, whereas for HNC,

Elekta Agility plans were re-planned for Elekta MLCi.

For prostate cases we identified rectum and bladder as

main OARs and for HNC contralateral parotid gland and

spinal cord. For PTV we evaluated variations in EUD, D

Mean

,

D

2%

and D

98%

and for OARs EUD and D

2%

.

Results

Automatic re-planning using constrained optimization was

successful in all cases. Auto-optimized plans never

corrupted OAR constraints, in some cases re-planning even

improved OAR sparing. The mean deviation (range) in

rectum EUD was 0,30% (-1,04 – -0,27%), bladder EUD 0,44%

(-1,08 – -0,13%), parotid EUD -0,34% (-14,79 – 8,23%) and

spinal cord EUD -0,02% (-0,49 – 0,31%). For the prostate

cases the mean EUD deviation in PTV was -0,15% (-0,57 –

0,56%) and for the HNC cases -0,60% for PTV_60 (-2,58

– -0,08%) and -0,79% (-3,44 – 0,20%) for PTV_54,

respectively. Except of 3 HNC cases, all evaluated

parameters for targets showed variations within ±1%. For

3 HN cases the target EUD is reduced by up to 3.44%,

indicated by λ > 10 * λ

avg

. Consequently, if all λ < 10* λ

avg

,

the original and the re-planned plan comply with the given

constraints and therefore represent the same optimal

point on the Pareto-front, which means they are equal in

terms of biological effect for targets and OAR.

Conclusion

This study showed that fully automatic re-planning by

taking a prescription list from previously optimized VMAT

plans is feasible and successful in terms of equal plan